Wolfgang Rehmann and Diana Heimhalt explain how proposed changes to the German Criminal Code may create new corruption offences in the private and healthcare sectors.
A legal toolkit for life sciences companies and their investors providing access to information on:
Paul England explores the patent and complementary means of protecting neural prosthetic devices against the backdrop of regulation of medical devices...read more
Matthew Royle and Paul England explain the recent decision of the CJEU in Teva v the European Medicines Agency regarding the ten-year exclusivity period for orphan medicinal products...read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...